QUANTITATIVE OBSERVATIONS WITH THE TRIIODOTHYRONINE SUPPRESSION TEST OF THYROID FUNCTION*
I. B. Hales, J. Myhill, T. H. ODDIE, M. Croydon
Abstract
I. B. Hales, J. Myhill, T. H. ODDIE, M. Croydon
Abstract
Triiodothyronine (T3), 120 to 150 μg. per day, was administered for seven days to 50 thyrotoxic patients and 109 euthyroid subjects. The thyroidal I131 uptake rate was determined before and during administration of T3. Diagnostic borderlines were determined by analysis of the ratios of these uptake rates. The triiodothyronine suppression test is a useful diagnostic aid, and is the suppression test of choice. Diagnostic data are obtained sooner and are less likely to be affected by prior antithyroid medication than with the thyroxine suppression test.
OpenAlex reports 25 citations for this work. Citation counts describe recorded attention and do not establish research quality.
A contribution statement is not available in the OpenAlex record.
Method details are not available in the OpenAlex metadata.
Findings are not separately available in the OpenAlex metadata.
Limitations are not available in the OpenAlex metadata.
Application details are not available in the OpenAlex metadata.
Triiodothyronine (T3), 120 to 150 μg. per day, was administered for seven days to 50 thyrotoxic patients and 109 euthyroid subjects. The thyroidal I131 uptake rate was determined before and during administration of T3. Diagnostic borderlines were determined by analysis of the ratios of these uptake rates. The triiodothyronine suppression test is a useful diagnostic aid, and is the suppression test of choice. Diagnostic data are obtained sooner and are less likely to be affected by prior antithyroid medication than with the thyroxine suppression test.
Key concepts: Euthyroid, Triiodothyronine, Medicine, Internal medicine, Endocrinology, Thyroid function tests, Antithyroid drugs, Thyroid function